Kim D - Search Results

1

A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma.

Kim CG, Hong MH, Kim D, Lee BH, Kim H, Ock CY, Kelly G, Bang YJ, Kim G, Lee JE, Kim C, Kim SH, Hong HJ, Park YM, Sim NS, Park H, Park JW, Lee CG, Kim KH, Park G, Jung I, Han D, Kim JH, Cha J, Lee I, Kang M, Song H, Oum C, Kim S, Kim S, Lim Y, Kim-Schulze S, Merad M, Yoon SO, Kim HJ, Koh YW, Kim HR. Kim CG, et al. Among authors: kim h, kim g, kim hj, kim d, kim sh, kim schulze s, kim c, kim s, kim hr, kim kh, kim jh. Clin Cancer Res. 2024 May 15;30(10):2097-2110. doi: 10.1158/1078-0432.CCR-23-3249. Clin Cancer Res. 2024. PMID: 38457288 Clinical Trial.

2

Overexpression of poliovirus receptor is associated with poor prognosis in head and neck squamous cell carcinoma patients.

Lim SM, Hong MH, Ha SJ, Hwang D, Chae S, Koh YW, Choi EC, Kim SH, Kim DH, Yoon SO, Kim HR. Lim SM, et al. Among authors: kim dh, kim sh, kim hr. J Cancer Res Clin Oncol. 2021 Sep;147(9):2741-2750. doi: 10.1007/s00432-021-03531-8. Epub 2021 Feb 22. J Cancer Res Clin Oncol. 2021. PMID: 33616718 Clinical Trial.

3

Transoral robotic surgery in patients with stage III/IV hypopharyngeal squamous cell carcinoma: treatment outcome and prognostic factor.

Park YM, Kim DH, Kang MS, Lim JY, Koh YW, Kim SH. Park YM, et al. Acta Otolaryngol. 2019 Sep;139(9):816-822. doi: 10.1080/00016489.2019.1631480. Epub 2019 Jul 3. Acta Otolaryngol. 2019. PMID: 31268399

4

Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancer.

Kang HN, Kim JH, Park AY, Choi JW, Lim SM, Kim J, Shin EJ, Hong MH, Pyo KH, Yun MR, Kim DH, Lee H, Yoon SO, Kim DH, Park YM, Byeon HK, Jung I, Paik S, Koh YW, Cho BC, Kim HR. Kang HN, et al. BMC Cancer. 2020 Apr 15;20(1):316. doi: 10.1186/s12885-020-06786-5. BMC Cancer. 2020. PMID: 32293356 Free PMC article.

5

Comprehensive Analysis of Clinicopathologic Factors Predictive of an Unfavorable Prognosis in Patients With Acinic Cell Carcinoma of the Parotid Gland.

Park YM, Yoon SO, Kim JH, Kang MS, Kim DH, Koh YW, Kim SH, Lim JY, Choi EC. Park YM, et al. Clin Exp Otorhinolaryngol. 2021 Feb;14(1):108-115. doi: 10.21053/ceo.2019.01550. Epub 2020 May 13. Clin Exp Otorhinolaryngol. 2021. PMID: 32392906 Free PMC article.

6

Disproportional enrichment of FoxP3⁺ CD4⁺ regulatory T cells shapes a suppressive tumour microenvironment in head and neck squamous cell carcinoma.

Park S, Kim CG, Kim D, Hong MH, Choi EC, Kim SH, Park YM, Kim J, Yoon SO, Kim G, Shin S, Kim K, Koh YW, Ha SJ, Kim HR. Park S, et al. Among authors: kim g, kim cg, kim d, kim sh, kim hr, kim j, kim k. Clin Transl Med. 2022 Mar;12(3):e753. doi: 10.1002/ctm2.753. Clin Transl Med. 2022. PMID: 35343075 Free PMC article. No abstract available.

7

Robot-Assisted Total Thyroidectomy with or without Robot-Assisted Neck Dissection in Pediatric Patients with Differentiated Thyroid Cancer.

Kim D, Sim NS, Kim D, Choi EC, Chang JW, Koh YW. Kim D, et al. J Clin Med. 2022 Jun 9;11(12):3320. doi: 10.3390/jcm11123320. J Clin Med. 2022. PMID: 35743391 Free PMC article.

8

A Clinical Trial of Combination Neoadjuvant Chemotherapy and Transoral Robotic Surgery in Patients with T3 and T4 Laryngo-Hypopharyngeal Cancer.

Park YM, Keum KC, Kim HR, Cho BC, Kim DH, Cho NH, Kim SH. Park YM, et al. Ann Surg Oncol. 2018 Apr;25(4):864-871. doi: 10.1245/s10434-017-6208-5. Epub 2017 Oct 30. Ann Surg Oncol. 2018. PMID: 29086129

9

Establishing the robotic surgery procedure and techniques for head and neck tumors: a single surgeon's experience of 945 cases.

Park YM, Kim DH, Kang MS, Lim JY, Choi EC, Kim SH, Koh YW. Park YM, et al. J Robot Surg. 2020 Dec;14(6):871-880. doi: 10.1007/s11701-020-01068-5. Epub 2020 Mar 23. J Robot Surg. 2020. PMID: 32206978

10

Molecular subtypes of oropharyngeal cancer show distinct immune microenvironment related with immune checkpoint blockade response.

Kim MH, Kim JH, Lee JM, Choi JW, Jung D, Cho H, Kang H, Hong MH, Heo SJ, Kim SH, Choi EC, Kim DH, Park YM, Kim S, Yoon SO, Koh YW, Cho BC, Kim HR. Kim MH, et al. Among authors: kim dh, kim sh, kim s, kim hr, kim jh. Br J Cancer. 2020 May;122(11):1649-1660. doi: 10.1038/s41416-020-0796-8. Epub 2020 Apr 1. Br J Cancer. 2020. PMID: 32235905 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53,194 results

Search Page